IP Library Granted Patent US 7,500,987
Granted Patent B2
US 7,500,987 · App. 10/534,374 · Granted Mar 10, 2009

Amorphous alloy stents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,500,987
App. No.
10/534,374
Granted
Mar 10, 2009
Kind
B2
Abstract

Stents made of bulk-solidifying amorphous alloys and methods of making such stents are provided.

Claims (44)

1. A stent of a radially compactable generally tubular body comprising a bulk-solidifying amorphous alloy, wherein the alloy is subjected to an elastic strain of at least 1.0% in a compacted form of the stent.

2. The stent described in claim 1 , wherein the amorphous alloy has an elastic strain of at least 1.5%.

3. The stent described in claim 1 , wherein the amorphous alloy has an elastic strain of at least 1.5%, and a yield strength of more than 1.4 Gpa.

4. The stent described in claim 1 , wherein the amorphous alloy has an elastic strain of at least 1.8%, and a yield strength of more than 1.9 Gpa.

5. The stent described in claim 1 , wherein the amorphous alloy is subjected to an elastic strain of at least 1.5% in a compacted form of the stent.

6. The stent described in claim 1 , wherein the amorphous alloy is subjected to an elastic strain of at least 1.8% in a compacted form of the stent.

7. The stent described in claim 1 , wherein the amorphous alloy is subjected to an elastic strain of less than 0.5% in an expanded form of the stent.

8. The stent described in claim 1 , wherein the amorphous alloy has a delta T of greater than 90° C.

9. The stent described in claim 1 , wherein the amorphous alloy is a Zr/Ti base bulk-solidifying amorphous alloy.

10. The stent described in claim 1 , wherein the stent has a cross-section selected from the group consisting of hexagonal and round.

11. The stent described in claim 1 , wherein the body comprises a plurality of pieces arranged in a conformation selected from the group consisting of coiled spring, helical wound spring coil, zigzag pattern, diamond shaped, and non-mesh designs.

12. The stent described in claim 1 , wherein the wall of the body has a plurality of aperture openings.

13. The stent described in claim 1 , wherein the body covers between 9 and 20% of a vessel into which the stent is implanted.

14. The stent described in claim 1 , wherein the body covers at least 80% of a vessel into which the stent is implanted.

15. The stent described in claim 1 , wherein the body comprises at least two tubular segments which overlap or abut to form a single tubular body.

16. The stent described in claim 1 , wherein the stent is self-expanding.

17. The stent described in claim 1 , wherein the body is branched.

18. The stent described in claim 1 , wherein the body has a wall thickness of less than 0.5 mm.

19. The stent described in claim 1 , wherein the body has a wall thickness of less than 0.25 mm.

20. The stent described in claim 1 , wherein the stent is one of either a stent graft or intraluminal graft.

21. A method of forming a stent, comprising:

providing a molten piece of bulk-solidifying amorphous alloy;

providing a mold in the shape of a desired stent component;

casting the molten amorphous alloy into a plurality of near-to-net shape stent components;

assembling a stent from the stent components; and

compacting the stent radially to form a compacted stent, wherein the amorphous alloy piece is subjected to an elastic strain of at least 1.0% during compacting.

22. The method as described in claim 21 , further comprising finishing an outer surface the stent, wherein the finishing is selected from a process selected from the group consisting of electro-polishing and chemical etching.

23. The method as described in claim 21 , further comprising modifying an outer surface of the stent by a treatment selected from the group consisting of chemical treatment, thermal treatment, and a combination thereof.

24. A method of forming a stent, comprising:

providing a feedstock a bulk-solidifying amorphous alloy;

heating the feedstock to around the glass transition temperature of the amorphous alloy;

providing a mold in the shape of a desired stent component;

molding the molten amorphous alloy into a plurality of near-to-net shape stent components;

assembling a stent from the stent components; and

compacting the stent radially to form a compacted stent, wherein the amorphous alloy piece is subjected to an elastic strain of at least 1.0% during compacting.

25. The method as described in claim 24 , further comprising finishing an outer surface the stent, wherein the finishing is selected from a process selected from the group consisting of electro-polishing and chemical etching.

26. The method as described in claim 24 , further comprising modifying an outer surface of the stent by a treatment selected from the group consisting of chemical treatment, thermal treatment, and a combination thereof.

27. A method of forming a stent comprising:

providing a tubular body made of a bulk-solidifying amorphous alloy;

processing the tubular body to form a pattern of surface features therein, wherein the surface features extend at least partially through the wall of the body; and

compacting the stent radially to form a compacted stent, wherein the amorphous alloy is subjected to an elastic strain of at least 1.0% during compacting.

28. The method as described in claim 27 , wherein the processing includes a manufacturing method selected from the group consisting of electrostatic discharge machining (EDM), chemical milling, ablation and laser cutting.

29. The method as described in claim 27 , further comprising finishing an outer surface the stent, wherein the finishing is selected from a process selected from the group consisting of electro-polishing and chemical etching.

30. The method as described in claim 27 , further comprising modifying an outer surface of the stent by a treatment selected from the group consisting of chemical treatment, thermal treatment, and a combination thereof.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Feb 19, 2016
From: APPLE INC.
To: CRUCIBLE INTELLECTUAL PROPERTY, LLC
Reel/Frame 037861/0073 →
SECURITY AGREEMENT Recorded Aug 6, 2010
From: CRUCIBLE INTELLECTUAL PROPERTY, LLC
To: APPLE INC.
Reel/Frame 024804/0149 →
CONTRIBUTION AGREEMENT Recorded Aug 6, 2010
From: LIQUIDMETAL TECHNOLOGIES, INC.
To: CRUCIBLE INTELLECTUAL PROPERTY, LLC
Reel/Frame 024804/0169 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2008
From: BASSLER, BRAD; PHAM, QUOC TRAN; PEKER, ATAKAN; OPIE, DAVID
To: LIQUIDMETAL TECHNOLOGIES, INC.
Reel/Frame 021238/0772 →